Faculty of Social Welfare and Health Sciences, School of Public Health, University of Haifa, Israel; The Liver Unit, Gastroenterology Department, Tel-Aviv Medical Center, Israel.
Faculty of Social Welfare and Health Sciences, School of Public Health, University of Haifa, Israel.
Ann Hepatol. 2019 Jul-Aug;18(4):578-584. doi: 10.1016/j.aohep.2019.03.006. Epub 2019 May 7.
There are inconsistent findings on the association between human non-alcoholic fatty liver disease (NAFLD) and vitamin D, perhaps due to insufficient specificity for gender and obesity status. We aimed to assess whether serum levels of 25-hydroxyvitamin D are associated with unexplained elevated alanine aminotransferase (ALT) in general population across gender and body mass index (BMI) levels.
A cross-sectional analysis of a population-based cohort with a nationwide-distribution using electronic medical database. The population consisted of individuals aged 20-60 years who underwent blood tests for ALT and vitamin D.
A total of 82,553 subjects were included (32.5% men, mean age 43.91±10.15 years). The prevalence of elevated ALT was higher among men and women with vitamin D insufficiency or deficiency, but in multivariate analysis, adjusting for: age, BMI, serum levels of glucose, total cholesterol, triglycerides, statin use and season, only the association among men remained significant for the vitamin D deficiency category (OR=1.16, 95%CI 1.04-1.29, P=0.010). Stratification by BMI revealed that only among normal weight and overweight men vitamin D deficiency was associated with elevated ALT (OR=1.27, 95%CI 1.01-1.59, P=0.041 and OR=1.27, 95%CI 1.08-1.50, P=0.003, respectively). No independent association was shown among women at all BMI categories.
In a "real-life" general population, the association between vitamin D deficiency and unexplained elevated ALT is specific for non-obese men. The clinical significance of vitamin D for human NAFLD should be further elucidated with attention for a modifying effect of gender and adiposity.
人体非酒精性脂肪性肝病(NAFLD)与维生素 D 之间的关联存在不一致的发现,这可能是由于对性别和肥胖状况的特异性不足。我们旨在评估血清 25-羟维生素 D 水平是否与一般人群中未明原因的丙氨酸氨基转移酶(ALT)升高有关,无论性别和体重指数(BMI)水平如何。
使用电子病历数据库对具有全国分布的基于人群的队列进行横断面分析。该人群由年龄在 20-60 岁之间的个体组成,他们接受了 ALT 和维生素 D 的血液检查。
共纳入 82553 名受试者(32.5%为男性,平均年龄为 43.91±10.15 岁)。维生素 D 不足或缺乏的男性和女性中,ALT 升高的患病率较高,但在多变量分析中,调整年龄、BMI、血糖、总胆固醇、甘油三酯、他汀类药物使用和季节因素后,仅维生素 D 缺乏与男性 ALT 升高相关(OR=1.16,95%CI 1.04-1.29,P=0.010)。按 BMI 分层显示,仅在正常体重和超重男性中,维生素 D 缺乏与 ALT 升高相关(OR=1.27,95%CI 1.01-1.59,P=0.041 和 OR=1.27,95%CI 1.08-1.50,P=0.003)。在所有 BMI 类别中,女性均未显示出独立的相关性。
在“现实生活”中的一般人群中,维生素 D 缺乏与未明原因的 ALT 升高之间的关联是针对非肥胖男性的。应进一步阐明维生素 D 对人体 NAFLD 的临床意义,并注意性别和肥胖的修饰作用。